Back to Agenda
EUPATI - THE EUROPEAN PATIENTS ACADEMY ON THERAPEUTIC INNOVATION – AN UNPRECEDENTED PUBLIC PRIVATE PARTNERSHIP TO EMPOWER PATIENTS TO ENGAGE AS REAL PARTNERS IN THE DRUG DEVELOPMENT PROCESS
Session Chair(s)
Jan Geissler, MBA
Managing Director
Patvocates, Germany
The aim of this session to share with the audience the rationale behind EUPATI, progress made since launch at the Copenhagen DIA last March, next steps and opportunities for engagement, i.e. how others can play a constructive role, including on cross-learning and synergies.
Speaker(s)
A Snapshot of EUPATI – who we are trying to reach and why this is so vital – case in point – the educated patient and clinical trials
Jan Geissler, MBA
Patvocates, Germany
Managing Director
Understanding the Information Patients Need and the Best Ways This Can Be Achieved – The EUPATI needs and gap analysis
Bella Starling
The Nowgen Centre, United Kingdom
Director of Public Programmes
Translating Patient Needs into Robust, Easily Accessible Quality Materials
Matthew May, MS
EUPATI, Switzerland
Programme Coordinator, EUPATI Project
Have an account?